Comments
Pfizer Connects Dots To Deliver Better Treatments
Newest First  |  Oldest First  |  Threaded View
Gary_EL
50%
50%
Gary_EL,
User Rank: Ninja
4/2/2014 | 7:47:14 PM
Re: It's not "promise"; it's results in the here and now
Yes, and it's particularly gratifying to see a long-term possibility morph into a life enhancing and life saving reality. Bravo to Pfizer.
Charlie Babcock
50%
50%
Charlie Babcock,
User Rank: Author
4/2/2014 | 5:59:45 PM
Matching up disease subsets with genomes
Spotting  a subset population with both the same disease and same genetic mutation is a huge breakthrough for human health. Before this, we could identify one or the other but big data techniques allow us to match them up. Way to go, Pfizer.
Alison_Diana
50%
50%
Alison_Diana,
User Rank: Author
4/2/2014 | 2:18:25 PM
In comparison...
Doug mentions that many pharmaceutical companies do amass and compare data but I wonder whether anyone knows more about these firms' big data programs? It would be interesting to see how they compare with Pfizer's system.
Alison_Diana
50%
50%
Alison_Diana,
User Rank: Author
4/2/2014 | 2:16:22 PM
The patient perspective
Now patients want more control over their health -- through ownership of EHRs, portals, and incorporation of fitness-tracking devices, etc. -- it's natural that consumers want to also review all available treatment options so they can discuss them with physicians. When you add to that consumers' growing fascination with genetics and family trees, I can see where businesses like Zibdy fit into the big healthcare picture. 
Alison_Diana
50%
50%
Alison_Diana,
User Rank: Author
4/2/2014 | 2:13:07 PM
Re: It's not "promise"; it's results in the here and now
That's why this is so exciting: Pfizer (and hopefully its competitors) are already seeing results from their investment in big data. And while some industries' investment in technology lead to bigger profits or improved customer service, in the case of pharmaceuticals the benefit can be saving lives or improving the qualify of life for those with a disease or other affliction (and profits, too, of course so they can continue their research into other medications). 

As pharma companies reduce the costs and the time it takes to develop drugs, this also holds promise for so-called orphan drugs and people with rare conditions that aren't necessarily profitable for drug-makers to research and try to cure or control. Kudos to Pfizer. This investment and use of big data is a win for the company and patients. 
ZibdyHealth01
50%
50%
ZibdyHealth01,
User Rank: Apprentice
4/2/2014 | 1:43:29 PM
Re: It's not "promise"; it's results in the here and now

An excellent article, we are glad that Pfizer is finally working on this. EMR data can be very powerful tool from pharmaceutical company's perspective. We have launched a platform, ZibdyHealth, which takes similar approach from patient's perspective based on linked patient records. Pfizer is putting their billions to good use to develop some novel drugs and we are offering similar capabilities to the patient for free to identify medications which work or not work based on their family medical history (FMH). In addition, EMR data is limited to USA and few other countries but our platform can be used by patients globally. The information from FMH is interesting as it not only includes genetics lineage but often families live in the same environment and have similar lifestyle.

Here is article about ZibdyHealth by David Carr publish only few days back http://goo.gl/myJ4kh

D. Henschen
100%
0%
D. Henschen,
User Rank: Author
4/2/2014 | 11:08:03 AM
It's not "promise"; it's results in the here and now
Commenters should read the whole story, not just the headline. The point here is that big data analysis has already led to breakthrough drugs. Pfizer isn't waiting for results, it has at least one such product in the market and many more in the pipeline.  
Li Tan
50%
50%
Li Tan,
User Rank: Ninja
4/2/2014 | 10:00:41 AM
Re: Good
Big-data has promising future and wide utilization in healthcare. I do hope that we will have a smart system with big data analytics behind so that our patients will receive good treatment. However, we cannot reply on it 100% and the judgement from experienced doctors is still mandatory.
Madhava verma dantuluri
100%
0%
Madhava verma dantuluri,
User Rank: Apprentice
4/2/2014 | 7:09:24 AM
Good
This is good that lots of promises and commitment for better treatment.


The Business of Going Digital
The Business of Going Digital
Digital business isn't about changing code; it's about changing what legacy sales, distribution, customer service, and product groups do in the new digital age. It's about bringing big data analytics, mobile, social, marketing automation, cloud computing, and the app economy together to launch new products and services. We're seeing new titles in this digital revolution, new responsibilities, new business models, and major shifts in technology spending.
Register for InformationWeek Newsletters
White Papers
Current Issue
InformationWeek Tech Digest - August 27, 2014
Who wins in cloud price wars? Short answer: not IT. Enterprises don't want bare-bones IaaS. Providers must focus on support, not undercutting rivals.
Flash Poll
Video
Slideshows
Twitter Feed
InformationWeek Radio
Archived InformationWeek Radio
Howard Marks talks about steps to take in choosing the right cloud storage solutions for your IT problems
Sponsored Live Streaming Video
Everything You've Been Told About Mobility Is Wrong
Attend this video symposium with Sean Wisdom, Global Director of Mobility Solutions, and learn about how you can harness powerful new products to mobilize your business potential.